Helveticoside Exhibited p53-dependent Anticancer Activity Against Colorectal Cancer.

@article{An2020HelveticosideEP,
  title={Helveticoside Exhibited p53-dependent Anticancer Activity Against Colorectal Cancer.},
  author={N. An and Ying Sun and Ligang Ma and Shengli Shi and Xiaoke Zheng and Weisheng Feng and Zhiming Shan and Yongguang Han and Le Zhao and Huiming Wu},
  journal={Archives of medical research},
  year={2020}
}
BACKGROUND Investigation into the anti-cancer activities of natural products and their derivatives represents an efficient approach to develop safe and effective chemotherapeutic agents for the treatment of colorectal cancer. Helveticoside is a biologically active component of the seed extract of Descurainia sophia. This compound has been reported to regulate the genes related to cell proliferation and apoptosis in lung cancer cells, however its anticancer activity has not been fully explored… Expand
1 Citations
Identification of a Metabolism-Related Risk Signature Associated With Clinical Prognosis in Glioblastoma Using Integrated Bioinformatic Analysis
TLDR
This study identified a novel metabolism-related gene signature associated with GBM prognosis, in addition the existence of three different metabolic status and two opposite biological processes in GBM were recognized, which revealed the metabolic heterogeneity of GBM. Expand

References

SHOWING 1-10 OF 22 REFERENCES
Dihydrotanshinone I induced apoptosis and autophagy through caspase dependent pathway in colon cancer.
  • L. Wang, T. Hu, +6 authors W. Wu
  • Biology, Medicine
  • Phytomedicine : international journal of phytotherapy and phytopharmacology
  • 2015
TLDR
Dihydrotanshinone I could be a promising leading compound for the development of anti-tumor agent or be developed as an adjuvant drug for colon cancer therapy. Expand
Dihydrotanshinone induces p53-independent but ROS-dependent apoptosis in colon cancer cells.
TLDR
It seems that leakage of ROS from mitochondria into cytosol by DHTS represents the major contributory factor leading to cell death in colon cancer cells. Expand
Tanshinone IIA enhances chemosensitivity of colon cancer cells by suppressing nuclear factor-κB.
TLDR
It is suggested that tanshinone IIA induces cell death and chemosensitizes colon cancer cells through the suppression of NF-κB signaling. Expand
Miltirone induced mitochondrial dysfunction and ROS-dependent apoptosis in colon cancer cells.
TLDR
Miltirone exhibited potent cytotoxicity on colon cancer cells with a better selectivity than that of dihydrotanshinone and the pro-apoptotic activity of miltirone was p53- and ROS-dependent. Expand
Cardiac glycosides induce autophagy in human non-small cell lung cancer cells through regulation of dual signaling pathways.
TLDR
This work provides first evidence showing that the cardiac glycosides induce autophagy in human NSCLC cells through regulation of both mTOR and ERK1/2 signaling pathways. Expand
Growth inhibition and apoptosis induction by tanshinone IIA in human colon adenocarcinoma cells.
TLDR
It is suggested that tanshinone IIA induces apoptosis in Colo-205 cells through both mitochondrial-mediated intrinsic and Fas-mediated extrinsic caspase cell-death pathways, and the chemotherapeutic potential of tanshine IIA for colon cancer warrants further study. Expand
Mechanisms of drug resistance in colon cancer and its therapeutic strategies.
TLDR
Given that the drug resistance mechanisms are different among colon cancer patients and may change even in a single patient at different stages, personalized and specific combination therapy is proposed to be more effective and safer for the reversal of drug resistance in clinics. Expand
Cardiac glycoside ouabain induces autophagic cell death in non-small cell lung cancer cells via a JNK-dependent decrease of Bcl-2.
TLDR
It is proposed that JNK activation by ouabain leads to a decrease of Bcl-2 levels, resulting in disruption of the inhibitory interaction of BCl-2 with Beclin 1, that promotes autophagy. Expand
The use of natural products in colorectal cancer drug discovery
TLDR
Natural products are evolutionarily designed and contain more complex and challenging structures than synthetic compounds and may be utilized for anti-cancer drug discovery including NPs for CRC. Expand
Natural products and colon cancer: current status and future prospects
TLDR
Recent studies on natural products in colon cancer chemoprevention with respect to multiple molecular mechanisms in various in vitro, in vivo, and clinical studies are described in this overview. Expand
...
1
2
3
...